Advertisement

Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies: Author´s reply

  • Ana Clara Ladeira Cruz
    Affiliations
    School of Medical Sciences, University of Campinas, Campinas, Brazil Rua Tessália Vieira de Camargo, 126. Cidade Universitária “Zeferino Vaz” CEP: 13083-887. Campinas, SP, Brazil
    Search for articles by this author
  • Marina Pereira Colella
    Affiliations
    Thrombosis and Haemostasis Unit, Hematology and Hemotherapy Center, University of Campinas. Rua Carlos Chagas, 480. Cidade Universitária “Zeferino Vaz” CEP: 13083-970, Campinas, SP, Brazil
    Search for articles by this author
  • Erich Vinícius De Paula
    Affiliations
    Thrombosis and Haemostasis Unit, Hematology and Hemotherapy Center, University of Campinas. Rua Carlos Chagas, 480. Cidade Universitária “Zeferino Vaz” CEP: 13083-970, Campinas, SP, Brazil

    Discipline of Hematology and Hemotherapy, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, Brazil Rua Tessália Vieira de Camargo, 126. Cidade Universitária “Zeferino Vaz” CEP: 13083-887. Campinas, SP, Brazil
    Search for articles by this author
  • Joyce Annichinno-Bizzachi
    Affiliations
    Thrombosis and Haemostasis Unit, Hematology and Hemotherapy Center, University of Campinas. Rua Carlos Chagas, 480. Cidade Universitária “Zeferino Vaz” CEP: 13083-970, Campinas, SP, Brazil

    Discipline of Hematology and Hemotherapy, Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, Brazil Rua Tessália Vieira de Camargo, 126. Cidade Universitária “Zeferino Vaz” CEP: 13083-887. Campinas, SP, Brazil
    Search for articles by this author
  • Fernanda Andrade Orsi
    Correspondence
    Corresponding author.
    Affiliations
    School of Medical Sciences, University of Campinas, Campinas, Brazil Rua Tessália Vieira de Camargo, 126. Cidade Universitária “Zeferino Vaz” CEP: 13083-887. Campinas, SP, Brazil

    Department of Clinical Pathology, School of Medical Sciences, University of Campinas, Campinas, Brazil Rua Tessália Vieira de Camargo, 126. Cidade Universitária ``Zeferino Vaz'' CEP: 13083-887. Campinas, SP, Brazil
    Search for articles by this author
Published:March 23, 2020DOI:https://doi.org/10.1016/j.ejim.2020.03.003
      Dear Editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yelnik C.M.N.Y.
        • Le Guern V.
        • Hachulla E.
        • Lambert M
        Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients?.
        Eur J Internal Med. 2020;
        • Miyakis S.
        • Lockshin M.D.
        • Atsumi T.
        • Branch D.W.
        • Brey R.L.
        • Cervera R.
        • et al.
        International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
        J Thrombosis Haemostasis. 2006; 4: 295-306
        • Abreu M.M.
        • Danowski A.
        • Wahl D.G.
        • Amigo M.C.
        • Tektonidou M.
        • Pacheco M.S.
        • et al.
        The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features.
        Autoimmun Rev. 2015; 14: 401-414
        • Cruz A.C.L.
        • Colella M.P.
        • De Paula E.V.
        • Annichinno-Bizzachi J.
        • Orsi F.A
        Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies.
        Eur J Intern Med. 2019; 69: e6-e7
        • Saraiva Sda S.
        • Custodio I.F.
        • Mazetto Bde M.
        • Collela M.P.
        • de Paula E.V.
        • Appenzeller S.
        • et al.
        Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory response.
        Thromb Res. 2015; 136: 1174-1178
        • Pontara E.
        • Banzato A.
        • Bison E.
        • Cattini M.G.
        • Baroni G.
        • Denas G.
        • et al.
        Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
        J Thrombosis Haemostasis. 2018; 16: 529-532
        • Favaloro E.J
        Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants.
        Int J Lab Hematol. 2013; 35: 269-274
        • Pengo V.
        • Tripodi A.
        • Reber G.
        • Rand J.H.
        • Ortel T.L.
        • Galli M.
        • et al.
        Update of the guidelines for lupus anticoagulant detection. subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and Haemostasis.
        J Thrombosis Haemostasis. 2009; 7: 1737-1740
        • Tripodi A.
        • Chantarangkul V.
        • Cini M.
        • Devreese K.
        • Dlott J.S.
        • Giacomello R.
        • et al.
        Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
        J Thrombosis Haemostasis. 2017; 15: 1180-1190
        • Rodeghiero F.
        • Stasi R.
        • Gernsheimer T.
        • Michel M.
        • Provan D.
        • Arnold D.M.
        • et al.
        Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
        Blood. 2009; 113: 2386-2393
        • Cervera R.
        • Tektonidou M.G.
        • Espinosa G.
        • Cabral A.R.
        • Gonzalez E.B.
        • Erkan D.
        • et al.
        Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria aps manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
        Lupus. 2011; 20: 165-173
        • Devreese K.M.J.
        • Ortel T.L.
        • Pengo V.
        • de Laat B.
        Subcommittee on lupus anticoagulant/antiphospholipid A. laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH.
        J Thrombosis Haemostasis. 2018; 16: 809-813